Alloga UK AP7 Pharmaceutical Import Profile — United Kingdom (DGFT 2022–2026)

Name: Alloga UK AP7 Pharmaceutical Import Records from India — 3 Products, $19.2M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Alloga UK AP7 — Pharmaceutical Importer Profile (2026) | 3 Products, $19.2M Trade | TransData Nexus

Alloga UK AP7

Pharmaceutical Importer · United Kingdom · Analgesics & Antipyretics Focus · $19.2M Total Trade · DGFT Verified

Alloga UK AP7 is a pharmaceutical importer based in United Kingdom with a total trade value of $19.2M across 3 products in 3 therapeutic categories. Based on 430 verified import shipments from Indian Customs (DGFT) records, the company actively imports across multiple product segments. Alloga UK AP7 sources from 5 verified Indian suppliers, with Zentiva Private Limited accounting for 60.4% of imports.

Alloga UK AP7 — Import Portfolio & Supplier Network

Alloga UK AP7 import network — 3 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to Alloga UK AP7?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Zentiva Private Limited	$20.9M	610	60.4%
Sanofi India Limited	$11.7M	258	34.0%
Rpg Life Sciences Limited	$1.7M

What Formulations Does Alloga UK AP7 Import?

Formulation	Value	Ships
Pharmaceutical products - paracetamol	$5.8M	149
Pharmaceutical products - co-codamol	$3.0M	59
Pharmaceutical products - clopidogrel	$2.1M	46
Pharmaceutical products - clopidogrel	$1.7M	39
Pharmaceutical article / ods / product / item - paracetamol	$930.7K	23
Pharmaceutical article / ods / product / item - co-codamol	$800.0K	16
Pharmaceutical products - co-codamol	$726.4K	15
Pharmaceutical products - codydramol	$665.6K	14
Pharmaceutical products - cocodamol	$559.4K	14
Nicorandil tablets 10MG [Pack	$338.9K	8
Pharamaceutical products paracetamol 500MG TAB bl10x10 m36	$316.6K	7
Pharmaceutical products - paracetamol 500MG TAB bl10x10 m36	$287.6K	8
Nicorandil tablets 20MG [Pack	$284.4K	6
Pharmaceutical products- cocodamol	$248.1K	6
Pharmaceutical products - clopidogrel 75MG tabco bl2x14 m36	$247.8K	6

Alloga UK AP7 imports 283 distinct pharmaceutical formulations. Showing top 15 by value. For full formulation-level data, contact TransData Nexus.

Import Portfolio — Top 3 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Paracetamol	Analgesics & Antipyretics	$9.6M	197	2.7%	2
2	Clopidogrel	Cardiovascular	$8.0M	187	3.2%	5
3	Fexofenadine	Antihistamines & Allergy	$1.5M	46	1.4%	16

Alloga UK AP7 imports 3 pharmaceutical products across 3 categories into United Kingdom totaling $19.2M.

Alloga UK AP7 — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

Alloga UK AP7 is a pharmaceutical importer and buyer based in the United Kingdom, specializing in the procurement of finished pharmaceutical formulations from India. Operating under the umbrella of Alloga UK Limited, the company plays a pivotal role in the UK's pharmaceutical distribution network. Alloga UK Limited, incorporated on 7 March 1996, is a private limited company headquartered at Amber Park, Berristow Lane, South Normanton, Derbyshire, DE55 2FH. (find-and-update.company-information.service.gov.uk)

As a key player in the pharmaceutical supply chain, Alloga UK AP7 is responsible for sourcing, importing, and distributing a diverse range of pharmaceutical products across the UK. The company's operations are integral to ensuring the availability of essential medications, thereby supporting the healthcare sector's needs. Alloga UK's extensive experience and infrastructure enable it to manage complex logistics and regulatory requirements associated with pharmaceutical imports.

2Distribution Network

Alloga UK AP7 operates a comprehensive distribution network designed to meet the diverse needs of the pharmaceutical market. The company's primary warehouse is located at Castlewood Business Park, Farmwell Lane, South Normanton, Derbyshire, DE55 2JX, England. This facility is part of a larger campus encompassing over 1.4 million square feet of warehousing space, equipped to handle a wide array of pharmaceutical products, including temperature-sensitive items.

Alloga UK's logistics capabilities include a fleet of vehicles ranging from heavy goods vehicles (HGVs) to vans, some of which are temperature-controlled to ensure the safe transport of sensitive pharmaceuticals. The company utilizes GPS systems to monitor its fleet, ensuring timely and secure deliveries. With coverage extending to 97% of UK postcodes, Alloga UK AP7's distribution network is both extensive and efficient, facilitating prompt delivery of pharmaceutical products nationwide.

3Industry Role

Alloga UK AP7 functions as a pharmaceutical importer and buyer within the United Kingdom's supply chain. Its primary role involves sourcing finished pharmaceutical formulations from Indian manufacturers and distributing them to various stakeholders in the UK healthcare sector. This includes supplying wholesalers, hospitals, pharmacies, and other healthcare providers with essential medications. By bridging the gap between Indian pharmaceutical manufacturers and the UK market, Alloga UK AP7 ensures a steady supply of critical drugs, contributing to the overall efficiency and reliability of the UK's pharmaceutical distribution system.

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — Alloga UK AP7

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

Alloga UK AP7's sourcing strategy exhibits a high degree of concentration, with a significant portion of its pharmaceutical imports originating from a select group of Indian suppliers. The top five suppliers account for 99.9% of the total import value, with ZENTIVA PRIVATE LIMITED leading at 60.4%, followed by SANOFI INDIA LIMITED at 34.0%. This concentrated sourcing approach suggests a strategic partnership model, potentially offering benefits such as favorable pricing, consistent product quality, and streamlined logistics.

However, this concentration also introduces risks associated with supplier dependency. Any disruptions within these key suppliers—such as production issues, regulatory challenges, or geopolitical events—could impact Alloga UK AP7's ability to meet market demand. The company's reliance on a limited number of suppliers necessitates robust risk management strategies, including maintaining open communication channels, conducting regular supplier evaluations, and developing contingency plans to mitigate potential supply chain disruptions.

2Supply Chain Resilience

Alloga UK AP7's supply chain resilience is closely tied to the stability and reliability of its Indian suppliers. The company's sourcing strategy, characterized by a concentrated supplier base, underscores the importance of these suppliers' operational stability. While this approach can lead to efficiencies and stronger supplier relationships, it also means that any disruptions—such as production delays, quality control issues, or regulatory challenges—could have a significant impact on Alloga UK AP7's ability to fulfill its obligations to UK customers.

Importing Pharmaceuticals into United Kingdom — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for United Kingdom

1Regulatory Authority & Framework

In the United Kingdom, the Medicines and Healthcare products Regulatory Agency (MHRA) serves as the primary regulatory authority overseeing the importation, distribution, and marketing of pharmaceutical products. The MHRA ensures that all medicinal products meet stringent safety, quality, and efficacy standards before they are made available to the public. Key legislation governing pharmaceutical imports includes the Human Medicines Regulations 2012, which transposes European Union directives into UK law, and the Medicines Act 1968, which provides the legal framework for the control of medicines.

For Indian pharmaceutical companies exporting to the UK, obtaining a Marketing Authorization (MA) from the MHRA is a critical step. This process involves submitting comprehensive data on the product's quality, safety, and efficacy, as well as information on manufacturing practices and facilities. The MHRA evaluates this information to ensure that the product complies with UK standards and regulations. Additionally, Indian exporters must adhere to Good Manufacturing Practice (GMP) standards recognized by the MHRA, which may include EU GMP, WHO GMP, or PIC/S certifications.

2Import Licensing & GMP

Import licensing requirements for pharmaceutical products in the UK are stringent, ensuring that all imported medicines meet the necessary safety and quality standards. Indian pharmaceutical companies seeking to export to the UK must obtain a Wholesale Distribution Authorization (WDA) from the MHRA, which permits the distribution of medicinal products within the UK. This authorization requires compliance with Good Distribution Practice (GDP) guidelines, ensuring that products are stored, transported, and handled appropriately throughout the supply chain.

Alloga UK AP7 — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

Alloga UK AP7's product category focus is primarily on Analgesics & Antipyretics (50.0%), Cardiovascular (42.0%), and Antihistamines & Allergy (8.0%). This strategic emphasis aligns with the prevalent healthcare needs in the UK, where there is a consistent demand for pain management, cardiovascular treatments, and allergy medications. The company's import strategy is driven by market demand, aiming to provide essential medications that address common health concerns among the UK population.

TransData Nexus Research · DGFT trade data analysisMar 2026

Frequently Asked Questions — Alloga UK AP7

What products does Alloga UK AP7 import from India?

Alloga UK AP7 imports 3 pharmaceutical products across 3 categories. Top imports: Paracetamol ($9.6M), Clopidogrel ($8.0M), Fexofenadine ($1.5M).

Who supplies pharmaceuticals to Alloga UK AP7 from India?

Alloga UK AP7 sources from 5 verified Indian suppliers. The primary supplier is Zentiva Private Limited (60.4% of imports, $20.9M).

What is Alloga UK AP7's total pharmaceutical import value?

Alloga UK AP7's total pharmaceutical import value from India is $19.2M, based on 430 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does Alloga UK AP7 focus on?

Alloga UK AP7 imports across 3 categories. The largest: Analgesics & Antipyretics (50.0%), Cardiovascular (42.0%), Antihistamines & Allergy (8.0%).

Get Full Alloga UK AP7 Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. For current shipment-level data, contact TransData Nexus.